ESC Premium Access

Discussion - GLP-1 RA in diabetes and cardiovascular disease - What are the key opportunities for cardiology practice

Topic: Diabetes and the Heart
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Novo Nordisk

Congress Session

About the speakers

Professor Thomas Felix Luscher

Royal Brompton and Harefield Hospital Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
37 presentations
0 follower

Professor Lars Ryden

Karolinska Institute, Stockholm (Sweden)
32 presentations
0 follower

Professor Stephan Jacob

Villingen (Germany)
8 presentations
0 follower

3 more presentations in this session

Introduction - Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice

Speaker: Professor T. Luscher (London, GB)

Thumbnail

Summary - GLP-1 receptor agonists - The cardiovascular benefits beyond glucose control.

Speaker: Professor S. Jacob (Villingen, DE)

Thumbnail

Summary - Translating GLP-1 trial outcomes to cardiology practice - Which patients will benefit?

Speaker: Professor L. Ryden (Stockholm, SE)

Thumbnail

Access the full session

Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice

Speakers: Professor T. Luscher, Professor L. Ryden, Professor S. Jacob, Professor T. Luscher, Professor S. Jacob...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk